Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01641055
Other study ID # 2011/572
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 2012
Est. completion date November 2012

Study information

Verified date March 2022
Source University of Bergen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the possible health benefits of intake of proteins from salmon, herring, cod and milk on glucose tolerance in overweight and obese adults. Overweight and obese subjects often have reduced glucose tolerance, and previous findings from a study on cod proteins suggested that glucose tolerance was improved.


Description:

Participants receive 2.5g protein per day for 8 weeks as tablets.


Recruitment information / eligibility

Status Completed
Enrollment 93
Est. completion date November 2012
Est. primary completion date November 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 69 Years
Eligibility Inclusion Criteria: - BMI above 27 kg/m2 - healthy Exclusion Criteria: - fasting blood glucose above 7 mM - medication that affects blood glucose, lipids and inflammatory status - pregnancy or breastfeeding - allergies to fish or milk - intentional weight loss and large fluctuation in body weight - a high consumption of fish - an extreme diet - use of fish oil, n-3 or multivitamin supplements

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Salmon protein hydrolysate
2.5g salmon protein hydrolysate per day for 8wk.
Herring protein hydrolysate
2.5g herring protein hydrolysate per day for 8wk.
Cod protein
2.5g cod protein per day for 8wk.
Milk protein
2.5g milk protein per day for 8wk.

Locations

Country Name City State
Norway Institute of Medicine, University of Bergen Bergen

Sponsors (3)

Lead Sponsor Collaborator
University of Bergen BlueProtein, NutriMar

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Glucose regulation Glucose will be measured in fasting and postprandial samples 8 weeks
Secondary Changes in serum insulin, insulin C-peptide, non-esterified fatty acids, lipids, adiponectin, leptin and fatty acid composition 8 weeks
Secondary Changes in serum and urine concentrations of amino acids and their metabolites 8 weeks
Secondary Changes in serum concentrations of vitamins 8 weeks
Secondary Comparisons of metabolites and co-factors involved in one-carbon metabolism in serum and urine Concentrations of relevant metabolites and co-factors were measured in serum and urine 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2